Recursion Pharmaceuticals(RXRX.US)

Last Updated 19:00:00 ET
longbridge loading

3 Stocks Poised to Disrupt the Healthcare Market by 2030

nasdaq·
US
AXSM
+1.74%
US
RXRX
+3.86%
US
TEM
+0.77%
nasdaq·
US
AXSM
+1.74%
US
RXRX
+3.86%
US
TEM
+0.77%

Recursion Eyes Breakthrough With REC-4881 Drug For Rare Genetic Condition, But Shares Pull Back

benzinga_article·
US
RXRX
+3.86%
US
PBE
+1.60%
US
LABU
+11.76%
benzinga_article·
US
RXRX
+3.86%
US
PBE
+1.60%
US
LABU
+11.76%

Recursion Pharmaceuticals Q1 Earnings Call Highlights

Market Beat·
US
RXRX
+3.86%
US
BIB
+4.98%
US
FBT
+2.14%
Market Beat·
US
RXRX
+3.86%
US
BIB
+4.98%
US
FBT
+2.14%

Recursion Pharmaceuticals (NASDAQ:RXRX) Issues Quarterly Earnings Results

Market Beat·
US
RXRX
+3.86%
US
IXJ
+0.35%
US
PBE
+1.60%
Market Beat·
US
RXRX
+3.86%
US
IXJ
+0.35%
US
PBE
+1.60%

Recursion Pharmaceuticals | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 6.472 M

Earnings Watch·
US
RXRX
+3.86%
Earnings Watch·
US
RXRX
+3.86%

Recursion Reports First Quarter Financial Results and Provides Business Update

Fidelity·
US
RXRX
+3.86%
US
BIB
+4.98%
US
BBH
+0.96%
Fidelity·
US
RXRX
+3.86%
US
BIB
+4.98%
US
BBH
+0.96%
© 2026 Longbridge｜Disclaimer